Meeder Advisory Services’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,444
Closed -$204K 767
2026
Q1
$204K Sell
3,444
-871
-20% -$56.5K 0.01% 651
2025
Q4
$266K Buy
+4,315
New +$264K 0.01% 566
2025
Q3
Sell
-2,597
Closed -$207K 648
2025
Q2
$207K Buy
+2,597
New +$217K 0.01% 579

Other funds holding PBH

Meeder Advisory Services's PBH Position: Q2 2026 in Review

Meeder Advisory Services sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 3,444 shares — an estimated $204K sold.

Meeder Advisory Services first reported a position in PBH in Q2 2025 and held it in 3 quarters. The position peaked at $266K in Q4 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Meeder Advisory Services reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Meeder Advisory Services sold 3,444 Prestige Consumer Healthcare shares in Q2 2026, an estimated $204K.
  • Meeder Advisory Services first reported a position in Prestige Consumer Healthcare in Q2 2025 and held it in 3 quarters.
  • Meeder Advisory Services's Prestige Consumer Healthcare position peaked at $266K in Q4 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.